-Author name in bold denotes the presenting author
-Asterisk * with author name denotes a Non-ASH member
Clinically Relevant Abstract denotes an abstract that is clinically relevant.

PhD Trainee denotes that this is a recommended PHD Trainee Session.

Ticketed Session denotes that this is a ticketed session.

731. Autologous Transplantation: Clinical and Epidemiological: Poster III

Symposia: Autologous Transplantation: Clinical and Epidemiological Program: Oral and Poster Abstracts
Type: Poster
Monday, December 11, 2023: 6:00 PM-8:00 PM
Halls G-H (San Diego Convention Center)

Oren Pasvolsky, MD1,2,3*, Curtis Marcoux, MD, MSc4*, Jianliang Dai, MS5*, Denái R. Milton, MS5*, Mark R. Tanner, PhD1*, Naureen Syed, MD1*, Qaiser Bashir, MD1, Samer A. Srour, MD1, Neeraj Y. Saini, MD1, Paul Lin, MD, PhD1, Jeremy Ramdial, MD1, Yago Nieto, MD, PhD1, Hans Lee, MD6, Krina K. Patel, MD, MSc6, Elisabet E. Manasanch, MD6, Partow Kebriaei, MD1, Sheeba K. Thomas, MD6, Donna M. Weber, MD6, Robert Z. Orlowski, MD, PhD7, Elizabeth J. Shpall, MD1, Richard E. Champlin, MD1 and Muzaffar H. Qazilbash, MD1

1Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
2Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Petah-Tikva, Israel
3Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
4Division of Hematology, Dalhousie University, Halifax, Canada
5Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX
6Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
7Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX

Oren Pasvolsky, MD1,2,3*, Sassine Ghanem, MD4,5, Denái R. Milton, MS6*, Mikael Rauf1*, Mark R. Tanner, PhD1*, Qaiser Bashir, MD1, Samer A. Srour, MD1, Neeraj Y. Saini, MD1, Paul Lin, MD, PhD1, Jeremy Ramdial, MD1, Yago Nieto, MD, PhD1, Hina N. Khan, MD1,7*, Partow Kebriaei, MD1, Hans Lee, MD8, Krina K. Patel, MD, MSc8, Sheeba K. Thomas, MD8, Donna M. Weber, MD8, Robert Z. Orlowski, MD, PhD9, Elizabeth J. Shpall, MD1, Richard E. Champlin, MD1 and Muzaffar H. Qazilbash, MD1

1Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
2Institute of Hematology, Davidoff Cancer Center, Rabin Medical Center, Petah-Tikva, Israel
3Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel
4Department of Medicine, Warren Alpert Medical School of Brown University, Providence, RI
5Lifespan Cancer Institute, Providence, RI
6Department of Biostatistics, The University of Texas MD Anderson Cancer Center, Houston, TX
7Department of Hematology/Oncology, McGovern Medical School, The University of Texas Health Sciences Center at Houston, Houston, TX
8Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
9Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX

Miri Zektser, MD1*, Katrina Hueniken2*, Michael Crump, MD3*, Anca Prica, MD, MSc3*, John Kuruvilla, MD, FRCPC4, Robert Kridel3, Rodger E. Tiedemann, MBChB, PhD5, Armand Keating, MD5 and Vishal Kukreti6

1Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, ON, Canada
2Department of Biostatistics, Princess Margaret Cancer Centre, Toronto, Canada
3Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre - University Health Network, Toronto, Canada
4Princess Margaret Cancer Centre, Toronto, ON, Canada
5Department of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Canada
6Division of Medical Oncology and Hematology, Princess Margaret Cancer Centre, Toronto, Canada

Brian C. Shaffer, MD1, Itzhak Zachi Attia, PhD2*, Grace Greason3*, Stephanie Chinapen4*, Samantha Brown5*, David Chung, MD, PhD6, Oscar Boutros Lahoud7,8, Francisco Lopez-Jimenez, MD3*, Wendy Schaffer, MD, PhD9*, Jennifer Liu, MD10*, Sergio A. Giralt, MD, FACP11, Gunjan L. Shah12, Heather Landau, MD7, Saad Z Usmani, MD6, Paul A Friedman, MD3*, Bernard J Gersh, M.B., Ch.B, D.Phil3*, Peter Noseworthy, MD3* and Ioanna Kosmidou, MD, PhD12*

1National Insitutes of Health, New York, NY
2Department of Cardiovascular Diseases, Mayo Clinic Rochester, Rochester, MN
3Mayo Clinic Rochester, Rochester, MN
4Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York
5Department of Biostatistics and Epidemiology, Memorial Sloan Kettering Cancer Center, New York, NY
6Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
7Department of Medicine, Weill Cornell Medical College, New York, NY
8Adult Bone Marrow Transplant Service, Division of Hematologic Oncology, Memorial Sloan Kettering Cancer Center, New York, NY
9Memorial Sloan-Kettering Cancer Center, New York, NY
10Department of Medicine, Cardiology, Memorial Sloan Kettering Cancer Center, New York
11Weill Cornell Medical College, Memorial Sloan Kettering Cancer Center, New York, NY
12Memorial Sloan Kettering Cancer Center, New York, NY

Sarah Tjards1*, Robin High, MBA, MA2*, Matthew A. Lunning, DO, FACP3*, Tanya M. Wildes, MD, MSc3, Julie M. Vose, MD, MBA4, Muhamed Baljevic, MD5*, Sarah A. Holstein, MD, PhD3 and Christopher R D'Angelo, MD6

1University of Nebraska Medicine, Omaha, NE
2Department of Biostatistics, University of Nebraska Medical Center, Omaha, NE
3Fred and Pamela Buffett Cancer Center/Division of Hematology and Oncology/Department of Internal Medicine, University of Nebraska Medical Center, Omaha, NE
4Fred and Pamela Buffett Cancer Center/Division of Hematology and Oncology/Department of Internal Medicine, Univeristy of Nebraska, Omaha, NE
5Vanderbilt-Ingram Cancer Center, Vanderbilt University Medical Center, Nashville, TN
6Division of Hematology & Oncology, Department of Internal Medicine, University of Nebraska Medical Center- Fred and Pamela Buffett Cancer Center, Omaha, NE

Luis Porrata, MD1, Stephen M Ansell, MD, PhD1, Ivana Micallef, MD2*, Patrick B Johnston, MD, PhD1*, J. C. C Villasboas, MD2*, Jonas Paludo, MD2, Urshila Durani, MD, MPH1 and Svetomir Markovic, MD, PhD3*

1Division of Hematology, Mayo Clinic, Rochester, MN
2Mayo Clinic, Rochester, MN
3Department of Medical Oncology, Mayo Clinic, Rochester, MN

Iku Kamitani1*, Hiroki Yokoyama, MD, PhD1*, Hiroto Ishii, MD, PhD1*, Susumu Tanoue2*, Daiki Hattori, MD1*, Takeshi Saito, MD, PhD1 and Shingo Yano, MD, PhD1

1Division of Clinical Oncology/Hematology, Department of Internal Medicine, The Jikei University School of Medicine, Tokyo, Japan
2Division of Clinical Oncology/Hematology, Department of Internal Medicine, The Jikei University School of Medicine, Kashiwa-Shi, CHI, Japan

Anand Jillella, MD1, Danielle Bradshaw, MD2*, Mohammad Mian, PhD3*, Jorge Cortes, MD1, Amany R. Keruakous, MD, MS1, Ayushi Chauhan, MD1, Locke Johnson Bryan, MD1, Molly Denlinger, MS4* and Vamsi K. Kota, MD1

1Georgia Cancer Center, Augusta University, Augusta, GA
2Augusta University, Augusta, GA
3Georgia Cancer Center, augusta, GA
4Georgia Cancer Center, Augusta, GA

David A Qualls, MD1,2, Gunjan L. Shah3, Roni Shouval, MD, PhD4, Philip Caron, MD5, Kevin A. David, MD6*, Lorenzo Falchi, MD7, Paola Ghione, MD, MSEpi3, Paul A. Hamlin, MD6, Steven M. Horwitz, MD3, Andrew M. Intlekofer, MD, DPhil5, William Johnson3*, Anita Kumar, MD8, Oscar Boutros Lahoud4,9,10, Jennifer Kimberly Lue, MD5, Alison Moskowitz, MD3, Ariela Noy, MD6, Maria Lia Palomba, MD5,6, Pallawi Torka, MD5, Santosha A Vardhana, MD, PhD6*, Andrew D. Zelenetz, MD, PhD5, Michelle Okwali, MPH6*, Parastoo Bahrami Dahi, MD11,12*, Michael Scordo4,9, Richard J. Lin, MD, PhD4,11, Miguel-Angel Perales, MD13,14 and Gilles Salles, MD, PhD5,9

1Division of Hematologic Malignancies, Dana Farber Cancer Institute, Boston, MA
2Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
3Memorial Sloan Kettering Cancer Center, New York, NY
4Adult Bone Marrow Transplant Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
5Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
6Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York
7Department of Medicine, Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY
8Lymphoma Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, Short Hills, NJ
9Department of Medicine, Weill Cornell Medical College, New York, NY
10Adult Bone Marrow Transplant Service, Division of Hematologic Oncology, Memorial Sloan Kettering Cancer Center, New York, NY
11Department of Medicine, Weill Cornell Medicine, New York, NY
12Adult Bone Marrow Transplantation Service, Memorial Sloan Kettering Cancer Center, New York, NY
13Department of Medicine, Weill Cornell Medical College, New York
14Adult Bone Marrow Transplantation Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY

Christianne Bourlon, MD, MSc1, Katharine Elizabeth Bailey1, Reuben Benjamin1*, Kirsty Cuthill1*, Arief Gunawan1*, Majid Kazmi2*, Pramila Krishnamurthy3*, Victoria Potter3*, Robin Sanderson4, Michelle Kenyon1*, Mili Shah3*, Matthew Streetly2*, Fabio Serpenti, MD5*, Stella J. Bowcock6*, Lalita Banerjee7*, John Robert Jones, MD8*, Sabia Rashid9*, Ana Isabel Duran Maestre9*, Satyajit Sahu9*, Sudarshan Gurung10*, Lianwea Chia11*, Haili Cui1*, Alison Pratt1*, Maheen Ahsan1* and Stella Bouziana, MD, PhD1*

1King´s College Hospital, King’s College Hospital NHS Foundation Trust, London, United Kingdom
2Guy´s and St Thomas´NHS Foundation Trust, London, United Kingdom
3Department of Haematological Medicine, King's College Hospital NHS, London, United Kingdom
4Department of Haematology, King’s College Hospital NHS Foundation Trust, London, United Kingdom
5King’s College Hospital NHS Foundation Trust, London, United Kingdom
6Princess Royal University Hospital, King’s College Hospital NHS Foundation Trust,, London, United Kingdom
7Maidstone and Tunbridge Wells NHS Trust, Kent, United Kingdom
8East Sussex Healthcare NHS Trust, Kent, GBR
9Lewisham and Greenwich NHS Trust, London, United Kingdom
10Medway NHS Trust, London, ENG, GBR
11Dartford and Gravesham NHS Trust, Kent, United Kingdom

Qaiser Bashir, MD1, Peter Thall2*, Dawen Sui, MS3*, Jitesh Kawedia, BPharm4*, Cristina Knape5*, Ruby Delgado5*, Jandi L Schindler5*, Uday R. Popat, MD1, Partow Kebriaei, MD1, Chitra Hosing, MD1, Issa F. Khouri, MD6, Yago Nieto, MD, PhD1, Betul Oran, MD, MS1*, Samer A. Srour, MD1, Neeraj Y. Saini, MD1, Amanda L. Olson, MD7, Sairah Ahmed, MD8, Gheath Alatrash, PhD, DO1, Gabriela Rondon, MD1, Hans Lee, MD9, Sheeba K. Thomas, MD10, Elisabet E. Manasanch, MD10, Krina K. Patel, MD, MSc11, Robert Z. Orlowski, MD, PhD12, Richard E. Champlin, MD1, Elizabeth J. Shpall, MD1 and Muzaffar H. Qazilbash, MD1

1Department of Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
2M.D. Anderson Cancer Center, Houston, TX
3MD Anderson Cancer Center, Houston
4Pharmacy, Univ. of Texas, MD Anderson Cancer Ctr., Houston, TX
5The University of Texas MD Anderson Cancer Center, Houston
6The University of Texas MD Anderson Cancer Center, Houston, TX
7Stem Cell Transplantation and Cellular Therapy, The University of Texas MD Anderson Cancer Center, Houston, TX
8Department of Lymphoma and Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
9Department of Lymphoma/Myeloma, MD Anderson Cancer Center, Houston, TX
10Department of Lymphoma & Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX
11University of Texas MD Anderson Cancer Center, Houston, TX
12Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, TX

Malek Benakli, MD1*, Arezki Tibiche2*, Nabil Yafour3*, Kamila Amani3*, Farah Bouamama3*, Leila Charef3*, Samira Bouchama3*, Khadidja Bouhafs3*, Amel Baki3*, Soufi Osmani3*, Mohamed Brahimi3*, Rachid Bouhass3*, Abdessamed Arabi3*, Mohamed Amine Bekadja3*, Farih Mehdid1*, Sabrina Akhrouf1*, Mounira Baazizi1*, Nadia Rahmoune1*, Dina Ait Ouali1*, Hanane Bouarab1*, Nacera Ait Amer1*, Farida Tensaout1*, Rihab Benouattas1*, Rachida Belhadj1*, Amina Talbi1*, Naima Abdennebi1*, Farida Harieche1*, Rose-Marie Hamladji1*, Redhouane Ahmed Nacer1*, Fatma Soltani4*, Mahbouba Ferrari4*, Mahdia Saidi4*, Salima Oukid5*, Cherifa Guezlane5*, Zohor Bouchetara5*, Mohand Tayeb Abad5*, Mohamed Bradai5*, Lina Kazi Tani6*, Naima Mesli6*, Mohamed Cherif Rahali7*, Mohamed Rafik Abadi7*, Samir Mnaouar7*, Khadidja Djouadi7*, Salahedine Belakehal7*, Samir Baghdad8*, Aissa Bachiri8*, Hadjira Ahmidatou9*, Soraya Kellouche9*, Nadia Boudjerra9*, Nawel Ferroudj9*, Salim Nekkal9*, Zohra Kaci9*, Yamina Bouchakor Moussa10*, Lynda Louanchi10* and Meriem Bensadok10*

1Pierre and Marie Curie Center, Algiers, Algeria
2CHU, Tizi Ouzou, Algeria
3EHU, Oran, Algeria
4CAC, Batna, Algeria
5CAC, Blida, Algeria
6CHU, Tlemcen, Algeria
7HCA, Algiers, Algeria
8HMRU, Oran, Algeria
9CHU Beni Messous, Algiers, Algeria
10SAHTS, Algiers, Algeria

Karen Sweiss, PharmD1, Craig C. Hofmeister, MD2, Ghulam Rehman Mohyuddin, MD3, Amandeep Godara, MD4, Brian McClune, DO3, Damiano Rondelli, MD5*, Danny Hadidi, MD5*, David Chan, PharmD6*, Matias Eugenio Sanchez, MD7, Min Hai, PhD Candidiate8*, Mitch A. Phelps, PhD8*, Chukwuemeka Uzoka, MD5 and Douglas Sborov, MD, MS9

1Department of Pharmacy Practice, University of Illinois at Chicago, Hinsdale, IL
2Department of Hematology and Medical Oncology, Winship Cancer Institute of Emory University, Atlanta, GA
3Huntsman Cancer Institute, University of Utah, Salt Lake City, UT
4Univ of Utah, Salt Lake City, UT
5Division of Hematology/Oncology, University of Illinois at Chicago, Chicago, IL
6Department of Pharmacy Practice, University of Illinois at Chicago, Chicago, IL
7Division of Hematology and Oncology, University of Illinois at Chicago, Chicago, IL
8The Ohio State University, Columbus, OH
9University of Utah School of Medicine, Salt Lake City, UT

*signifies non-member of ASH